Zymeworks

Zymeworks is a privately-held biotherapeutics company located in Vancouver, British Columbia. Zymeworks is committed to developing first-class protein therapies for the treatment of cancer, autoimmune diseases, and inflammatory conditions. Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this method, Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization.